TP53 and ovarian carcinoma: Bridging these concepts, we investigated the relationship between oviductal epithelial (OVE) cell p53 status (wild-type, p53R175H mutant or Trp53 knockout) on mevalonate pathway expression, ovarian cancer disease progression and sensitivity to statin drugs.